TREA

79348988 - MEPSGEN

Follow

Information

  • Trademark
  • 79348988
  • Serial Number
    79348988
  • Registration Number
    7490516
  • Filing Date
    April 28, 2022
    2 years ago
  • Registration Date
    September 03, 2024
    4 months ago
  • Transaction Date
    December 03, 2024
    a month ago
  • Status Date
    September 03, 2024
    4 months ago
  • Published for Opposition Date
    June 18, 2024
    7 months ago
  • Location Date
    September 02, 2024
    4 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    CORNWELL, ANDREA
  • Attorney Docket Number
    S26533
    Attorney Name
    LEIGH ANN LINDQUIST
  • Owners
Information
Mark Drawing Code
4
Mark Identification
MEPSGEN
Case File Statements
  • GS0091: Biochips for research or scientific purposes; biochip analyzing apparatus, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for inspecting biochips for laboratory use, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for analyzing biochips for laboratory use, namely, electronic biochip analysis device for analyzing functionality of biochips; apparatus for manufacturing biochips for laboratory use, namely, electronic installations for the remote control of industrial biochip manufacturing operations; laboratory apparatus for analyzing biological pharmaceuticals, namely, laboratory analysis device for analyzing efficacy, potency, and toxicity evaluations of biological pharmaceuticals; microchips
  • GS0051: Pharmaceutical products for treating respiratory diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; stimulants for the central nervous system; pharmaceutical preparations for tumor treatment; tissue- regenerative pharmaceutical preparations; pharmaceutical preparations for use in tissue transplantation; clinical diagnostic reagents; clinical medical reagents; pharmaceuticals for the treatment of Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, Cancer, Brain disease; pharmaceutical compositions for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; pharmaceutical drugs for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; cells for medical purposes; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the prevention of inflammatory disorders; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for immunity adjustment; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the prevention of diseases of the endocrine system; pharmaceutical products for the treatment of infectious diseases
  • GS0351: Wholesale store services featuring cell growth media for growing cells for use in scientific research; retail store services featuring cell growth media for growing cells for use in scientific research; wholesale store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; retail store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; wholesale store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring cardiovascular pharmaceuticals; retail store services featuring cardiovascular pharmaceuticals; wholesale store services featuring chemico-pharmaceutical preparations; retail store services featuring chemico-pharmaceutical preparations; wholesale store services featuring medical instruments; retail store services featuring medical instruments; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring biological preparations for medical or veterinary purposes; retail store services featuring biological preparations for medical or veterinary purposes; wholesale store services featuring biotechnological preparations for medical purposes; retail store services featuring biotechnological preparations for medical purposes; wholesale store services featuring biological reagents for medical purposes; retail store services featuring biological reagents for medical purposes; wholesale store services featuring biological tissue cultures for medical purposes; retail store services featuring biological tissue cultures for medical purposes; wholesale store services featuring biological preparations for medical purposes; retail store services featuring biological preparations for medical purposes; wholesale store services featuring living cells for medical purposes; retail store services featuring living cells for medical purposes; wholesale store services featuring cells for medical purposes; retail store services featuring cells for medical purposes; wholesale store services featuring cell culture instruments for medical use; retail store services featuring cell culture instruments for medical use; wholesale store services featuring cardiovascular agents for medical purposes; retail store services featuring cardiovascular agents for medical purposes; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring stem cells for medical purposes; retail store services featuring stem cells for medical purposes; wholesale store services featuring chemical preparations for medical purposes; retail store services featuring chemical preparations for medical purposes
  • GS0101: Medical diagnostic apparatus for the detection of cardiovascular diseases; medical apparatus and instruments for use in medical examination and treatment of cardiovascular diseases; cell culture instruments for medical use, namely, cell culture chambers
  • GS0421: Crude medicines research; drug discovery services; development of cell therapy products; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; pharmaceutical drug development; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical studies in the nature of medical and scientific research, namely, conducting clinical trials for others, and translational research and medical and scientific research; scientific research services for medical purposes in the field of cancerous diseases, CNS diseases, and brain diseases; drug delivery, medicinal effect, Biological or biotechnological research for medical products; development of biotechnology, namely, medical drug and biochip products; biotechnology research; laboratory research in the field of biology; development of biologics, namely, vaccine and therapeutic drug products; research in the field of chemistry; technological studies in the nature of biotechnology and microfluidics research; research and development of medical equipment; development of medical devices; conducting clinical trials in the field of cardiovascular disease; conducting early efficacy, potency, and toxicity evaluations in the field of new pharmaceuticals; conducting early pharmaceutical product evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection, research of medical products; consultancy in the field of testing, inspection, and research of medical products, namely, pharmaceuticals, pharmaceutical preparations and pharmaceutical compositions; pharmaceutical product evaluation; design of devices for biological medicine analysis; development of devices for biological chemicals analysis; development of devices for biochemical chemicals; microchip design services
Case File Event Statements
  • 9/8/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 9/9/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/13/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/16/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/24/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/25/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/17/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/17/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/10/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/17/2023 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/17/2023 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/18/2023 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/1/2023 - a year ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 11/1/2023 - a year ago
    14 - DATA MODIFICATION COMPLETED Type: DMCC
  • 11/14/2023 - a year ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 11/14/2023 - a year ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 11/14/2023 - a year ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/29/2024 - 9 months ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/29/2024 - 9 months ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/14/2024 - 11 months ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/14/2024 - 11 months ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 3/3/2024 - 10 months ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 4/29/2024 - 9 months ago
    21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 5/14/2024 - 8 months ago
    24 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 5/14/2024 - 8 months ago
    25 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 5/14/2024 - 8 months ago
    26 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 5/16/2024 - 8 months ago
    27 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/16/2024 - 8 months ago
    28 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/16/2024 - 8 months ago
    30 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/16/2024 - 8 months ago
    29 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/16/2024 - 8 months ago
    31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/16/2024 - 8 months ago
    32 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 5/29/2024 - 8 months ago
    33 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/11/2024 - 7 months ago
    34 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 6/11/2024 - 7 months ago
    35 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/18/2024 - 7 months ago
    36 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/18/2024 - 7 months ago
    37 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/1/2024 - 6 months ago
    38 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 9/3/2024 - 4 months ago
    39 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/3/2024 - 4 months ago
    40 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/3/2024 - a month ago
    41 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR